Retrospective study of treatment outcomes after postoperative chemoradiotherapy in Japanese oral squamous cell carcinoma patients with risk factors of recurrence

被引:12
作者
Hasegawa, Takumi [1 ]
Yanamoto, Souichi [2 ]
Otsuru, Mitsunobu [3 ]
Yamada, Shin-ichi [4 ]
Minamikawa, Tsutomu [1 ]
Shigeta, Takashi [1 ]
Naruse, Tomofumi [2 ]
Suzuki, Takatsugu [3 ]
Sasaki, Masashi [3 ]
Ota, Yoshihide [3 ]
Umeda, Masahiro [2 ]
Komori, Takahide [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kobe, Hyogo, Japan
[2] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oral Oncol, Nagasaki, Japan
[3] Tokai Univ, Sch Med, Div Surg, Dept Oral & Maxillofacial Surg, Isehara, Kanagawa, Japan
[4] Shinshu Univ, Sch Med, Dept Dent & Oral Surg, Matsumoto, Nagano, Japan
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY | 2017年 / 123卷 / 05期
关键词
LOCALLY ADVANCED HEAD; NECK-CANCER; CONCURRENT CHEMORADIOTHERAPY; 3-WEEKLY CISPLATIN; RADIATION-THERAPY; PHASE-III; CHEMOTHERAPY; RADIOTHERAPY; FEASIBILITY; DOCETAXEL;
D O I
10.1016/j.oooo.2016.11.014
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background. The purpose of this study was to investigate the feasibility of postoperative concomitant chemoradiotherapy (CRT) with cisplatin (CDDP), and compare the prognosis in 3 groups-without postoperative therapy (S-only), with radiotherapy (RT) alone (S+RT), and with CRT (S+CRT) din oral squamous cell carcinoma (OSCC) patients at high risk of recurrence. Methods. Clinicopathologic data and treatment modality were investigated. Endpoints evaluated were locoregional control (LRC), relapse-free survival, overall survival (OS), and type of recurrence. Results. The S+CRT group was associated with a better LRC rate than the S-only (P < .001) and S+RT groups (P = .044). However, there was no significant difference in OS rates between the S+RT and S+CRT groups. Conclusion. The addition of concomitant CDDP to postoperative RT improved LRC. However, there may be no benefit from the addition of concomitant CDDP to postoperative RT for improvement of distant metastasis and OS rates in OSCC patients.
引用
收藏
页码:524 / 530
页数:7
相关论文
共 24 条
[1]   Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24 [J].
AlSarraf, M ;
Pajak, TF ;
Byhardt, RW ;
Beitler, JJ ;
Salter, MM ;
Cooper, JS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (04) :777-782
[2]   Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522 [J].
Ang, K. Kian ;
Zhang, Qiang ;
Rosenthal, David I. ;
Nguyen-Tan, Phuc Felix ;
Sherman, Eric J. ;
Weber, Randal S. ;
Galvin, James M. ;
Bonner, James A. ;
Harris, Jonathan ;
El-Naggar, Adel K. ;
Gillison, Maura L. ;
Jordan, Richard C. ;
Konski, Andre A. ;
Thorstad, Wade L. ;
Trotti, Andy ;
Beitler, Jonathan J. ;
Garden, Adam S. ;
Spanos, William J. ;
Yom, Sue S. ;
Axelrod, Rita S. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :2940-+
[3]   Defining risk levels in locally advanced head and neck cancers:: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501) [J].
Bernier, J ;
Cooper, JS ;
Pajak, TF ;
van Glabbeke, M ;
Bourhis, J ;
Forastiere, A ;
Ozsahin, EM ;
Jacobs, JR ;
Jassem, J ;
Ang, KK ;
Lefèbvre, JL .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (10) :843-850
[4]   Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer [J].
Bernier, J ;
Domenge, C ;
Ozsahin, M ;
Matuszewska, K ;
Lefèbvre, JL ;
Greiner, RH ;
Giralt, J ;
Maingon, P ;
Rolland, F ;
Bolla, M ;
Cognetti, F ;
Bourhis, J ;
Kirkpatrick, A ;
van Glabbeke, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1945-1952
[5]   Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck [J].
Cooper, Jay S. ;
Zhang, Qiang ;
Pajak, Thomas F. ;
Forastiere, Arlene A. ;
Jacobs, John ;
Saxman, Scott B. ;
Kish, Julie A. ;
Kim, Harold E. ;
Cmelak, Anthony J. ;
Rotman, Marvin ;
Lustig, Robert ;
Ensley, John F. ;
Thorstad, Wade ;
Schultz, Christopher J. ;
Yom, Sue S. ;
Ang, K. Kian .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (05) :1198-1205
[6]   Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck [J].
Cooper, JS ;
Pajak, TF ;
Forastiere, AA ;
Jacobs, J ;
Campbell, BH ;
Saxman, SB ;
Kish, JA ;
Kim, HE ;
Cmelak, AJ ;
Rotman, M ;
Machtay, M ;
Ensley, JF ;
Chao, KSC ;
Schultz, CJ ;
Lee, N ;
Fu, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1937-1944
[7]  
Glisson BS, 2002, ONCOLOGY-NY, V16, P83
[8]   Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234 [J].
Harari, Paul M. ;
Harris, Jonathan ;
Kies, Merrill S. ;
Myers, Jeffrey N. ;
Jordan, Richard C. ;
Gillison, Maura L. ;
Foote, Robert L. ;
Machtay, Mitchell ;
Rotman, Marvin ;
Khuntia, Deepak ;
Straube, William ;
Zhang, Qiang ;
Ang, Kian .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (23) :2486-U290
[9]   Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study [J].
Harrington, Kevin ;
Temam, Stephane ;
Mehanna, Hisham ;
D'Cruz, Anil ;
Jain, Minish ;
D'Onofrio, Ida ;
Manikhas, Georgy ;
Horvath, Zsuzsanna ;
Sun, Yan ;
Dietzsch, Stefan ;
Dubinsky, Pavol ;
Holeckova, Petra ;
El-Hariry, Iman ;
Franklin, Natalie ;
Biswas-Baldwin, Nigel ;
Legenne, Philippe ;
Wissel, Paul ;
Netherway, Thelma ;
Farrell, John ;
Ellis, Catherine ;
Wang-Silvanto, Jing ;
Amonkar, Mayur ;
Ahmed, Nazma ;
Santillana, Sergio ;
Bourhis, Jean .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (35) :4202-+
[10]   Dose intensity comparison between weekly and 3-weekly Cisplatin delivered concurrently with radical radiotherapy for head and neck cancer: A retrospective comparison from New Cross Hospital, Wolverhampton, UK [J].
Ho, Kean F. ;
Swindell, Ric ;
Brammer, Caroline V. .
ACTA ONCOLOGICA, 2008, 47 (08) :1513-1518